Literature DB >> 16981270

Differential reactivity of mouse monoclonal anti-HBs antibodies with recombinant mutant HBs antigens.

Azam Roohi1, Yaghoub Yazdani, Jalal Khoshnoodi, Seyed Mohammad Jazayeri, William F Carman, Mahmood Chamankhah, Manley Rashedan, Fazel Shokri.   

Abstract

AIM: To investigate the reactivity of a panel of 8 mouse anti-hepatitis B surface antigen (HBsAg) monoclonal antibodies (mAbs) using a collection of 9 recombinant HBsAg mutants with a variety of amino acid substitutions mostly located within the "a" region.
METHODS: The entire HBs genes previously cloned into a mammalian expression vector were transiently transfected into COS7 cells. Two standard unmutated sequences of the ayw and adw subtypes served as controls. Secreted mutant proteins were collected and measured by three commercial diagnostic immunoassays to assess transfection efficiency. Reactivity of anti-HBs mAbs with mutated HBsAgs was determined by sandwich enzyme-linked immunosorbent assay (ELISA).
RESULTS: Reactivity of anti-HBs mAbs with mutated HBsAgs revealed different patterns. While three mutants reacted strongly with all mAbs, two mutants reacted weakly with only two mAbs and the remaining proteins displayed variable degrees of reactivity towards different mAbs. Accordingly, four groups of mAbs with different but overlapping reactivity patterns could be envisaged. One group consisting of two mAbs (37C5-S7 and 35C6-S11) was found to recognize stable linear epitopes conserved in all mutants. Mutations outside the "a" determinant at positions 120 (P-->S), 123(T-->N) and 161 (M-->T) were found to affect reactivity of these mAbs.
CONCLUSION: Our findings could have important implications for biophysical studies, vaccination strategies and immunotherapy of hepatitis B virus (HBV) mutants.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16981270      PMCID: PMC4088207          DOI: 10.3748/wjg.v12.i33.5368

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

1.  Analysis of T-cell receptor beta chain variable gene segment usage in healthy adult responders and nonresponders to recombinant hepatitis B vaccine.

Authors:  P Soroosh; F Shokri; M Azizi; M Jeddi-Tehrani
Journal:  Scand J Immunol       Date:  2003-05       Impact factor: 3.487

2.  Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes.

Authors:  V Barnaba; A Franco; A Alberti; R Benvenuto; F Balsano
Journal:  Nature       Date:  1990-05-17       Impact factor: 49.962

3.  Molecular analysis of antigenicity and immunogenicity of a vaccine-induced escape mutant of hepatitis B virus.

Authors:  Toru Shizuma; Kiyoshi Hasegawa; Kayo Ishikawa; Takuma Naritomi; Aiko Iizuka; Naoko Kanai; Miho Ogawa; Nobuyuki Torii; Riho Joh; Naoaki Hayashi
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

4.  Subtype specificity of anti-HBs antibodies produced by human B-cell lines isolated from normal individuals vaccinated with recombinant hepatitis B vaccine.

Authors:  Mohammad Ali Shokrgozar; Fazel Shokri
Journal:  Vaccine       Date:  2002-05-22       Impact factor: 3.641

5.  Transmission of G145R mutant of HBV to an unrelated contact.

Authors:  Varsha Thakur; Syed N Kazim; Rajkumar C Guptan; Seyed E Hasnain; Angeline Bartholomeusz; V Malhotra; Shiv K Sarin
Journal:  J Med Virol       Date:  2005-05       Impact factor: 2.327

6.  Hepatitis B surface antigen presentation and HLA-DRB1*- lessons from twins and peptide binding studies.

Authors:  A Kruger; P Adams; J Hammer; W O Böcher; P M Schneider; C Rittner; T Hoehler
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

7.  Epitope mapping of recombinant hepatitis B surface antigen by murine monoclonal antibodies.

Authors:  A Roohi; J Khoshnoodi; A H Zarnani; F Shokri
Journal:  Hybridoma (Larchmt)       Date:  2005-04

8.  At least three epitopes are recognized by the human repertoire in the hepatitis B virus group a antigen inducing protection; possible consequences for seroprevention and serodiagnosis.

Authors:  P Maillard; J Pillot
Journal:  Res Virol       Date:  1998 May-Jun

9.  Mutants of the hepatitis B virus surface antigen that define some antigenically essential residues in the immunodominant a region.

Authors:  P G Ashton-Rickardt; K Murray
Journal:  J Med Virol       Date:  1989-11       Impact factor: 2.327

10.  Epidemiology and Prevention of Hepatitis B Virus Infection.

Authors:  Jinlin Hou; Zhihua Liu; Fan Gu
Journal:  Int J Med Sci       Date:  2005-01-05       Impact factor: 3.738

View more
  4 in total

1.  Encapsulation of Leflunomide (LFD) in a novel niosomal formulation facilitated its delivery to THP-1 monocytic cells and enhanced Aryl hydrocarbon receptor (AhR) nuclear translocation and activation.

Authors:  Mahsa Hasani; Neda Abbaspour Sani; Behnaz Khodabakhshi; Mehdi Sheikh Arabi; Saeed Mohammadi; Yaghoub Yazdani
Journal:  Daru       Date:  2019-08-20       Impact factor: 3.117

2.  The expansion of CD14+ CD163+ subpopulation of monocytes and myeloid cells-associated cytokine imbalance; candidate diagnostic biomarkers for celiac disease (CD).

Authors:  Omid Babania; Saeed Mohammadi; Esmat Yaghoubi; Ahmad Sohrabi; Fakhri Sadat Seyedhosseini; Nafiseh Abdolahi; Yaghoub Yazdani
Journal:  J Clin Lab Anal       Date:  2021-08-27       Impact factor: 2.352

3.  Development of a sensitive enzyme-linked immunosorbent assay for detection of hepatitis B surface antigen using novel monoclonal antibodies.

Authors:  Yaghoub Yazdani; Azam Roohi; Jalal Khoshnoodi; Fazel Shokri
Journal:  Avicenna J Med Biotechnol       Date:  2010-10

4.  Preliminary Assessment of Various Additives on the Specific Reactivity of Anti- rHBsAg Monoclonal Antibodies.

Authors:  Yaghoub Yazdani; Saeed Mohammadi; Mehdi Yousefi; Fazel Shokri
Journal:  Avicenna J Med Biotechnol       Date:  2015 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.